---
document_datetime: 2025-09-24 11:05:13
document_pages: 2
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/avtozma-epar-all-authorised-presentations_en.pdf
document_name: avtozma-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 2.8406767
conversion_datetime: 2025-12-22 09:14:26.430345
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form                   | Route of Administration   | Immediate Packaging                           | Content (concentration)   | Pack size                                  |
|------------------|-------------------|------------|---------------------------------------|---------------------------|-----------------------------------------------|---------------------------|--------------------------------------------|
| EU/1/24/1896/001 | Avtozma           | 20 mg/ml   | Concentrate for solution for infusion | Intravenous use           | vial (glass)                                  | 4 ml                      | 1 vial                                     |
| EU/1/24/1896/002 | Avtozma           | 20 mg/ml   | Concentrate for solution for infusion | Intravenous use           | vial (glass)                                  | 4 ml                      | 4 vials                                    |
| EU/1/24/1896/003 | Avtozma           | 20 mg/ml   | Concentrate for solution for infusion | Intravenous use           | vial (glass)                                  | 10 ml                     | 1 vial                                     |
| EU/1/24/1896/004 | Avtozma           | 20 mg/ml   | Concentrate for solution for infusion | Intravenous use           | vial (glass)                                  | 10 ml                     | 4 vials                                    |
| EU/1/24/1896/005 | Avtozma           | 20 mg/ml   | Concentrate for solution for infusion | Intravenous use           | vial (glass)                                  | 20 ml                     | 1 vial                                     |
| EU/1/24/1896/006 | Avtozma           | 20 mg/ml   | Concentrate for solution for infusion | Intravenous use           | vial (glass)                                  | 20 ml                     | 4 vials                                    |
| EU/1/24/1896/007 | Avtozma           | 162 mg     | Solution for injection                | Subcutaneous use          | pre-filled syringe (glass)                    | 0.9 ml (180 mg/ml)        | 1 pre-filled syringe                       |
| EU/1/24/1896/008 | Avtozma           | 162 mg     | Solution for injection                | Subcutaneous use          | pre-filled syringe (glass)                    | 0.9 ml (180 mg/ml)        | 4 pre-filled syringes                      |
| EU/1/24/1896/009 | Avtozma           | 162 mg     | Solution for injection                | Subcutaneous use          | pre-filled syringe (glass)                    | 0.9 ml (180 mg/ml)        | 12 (3 x 4) pre-filled syringes (multipack) |
| EU/1/24/1896/010 | Avtozma           | 162 mg     | Solution for injection                | Subcutaneous use          | pre-filled syringe (glass) in pre- filled pen | 0.9 ml (180 mg/ml)        | 1 pre-filled pen                           |
| EU/1/24/1896/011 | Avtozma           | 162 mg     | Solution for injection                | Subcutaneous use          | pre-filled syringe (glass) in pre- filled pen | 0.9 ml (180 mg/ml)        | 4 pre-filled pens                          |
| EU/1/24/1896/012 | Avtozma           | 162 mg     | Solution for injection                | Subcutaneous use          | pre-filled syringe (glass) in pre- filled pen | 0.9 ml (180 mg/ml)        | 12 (3 x 4) pre-filled pens (multipack)     |
| EU/1/24/1896/013 | Avtozma           | 162 mg     | Solution for injection                | Subcutaneous use          | pre-filled syringe (glass)                    | 0.9 ml (180 mg/ml)        | 2 pre-filled syringes                      |

<div style=\"page-break-after: always\"></div>

| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form    | Route of Administration   | Immediate Packaging                           | Content (concentration)   | Pack size         |
|------------------|-------------------|------------|------------------------|---------------------------|-----------------------------------------------|---------------------------|-------------------|
| EU/1/24/1896/014 | Avtozma           | 162 mg     | Solution for injection | Subcutaneous use          | pre-filled syringe (glass) in pre- filled pen | 0.9 ml (180 mg/ml)        | 2 pre-filled pens |